What's new? Log in Free sign up

Eloxx Pharmaceuticals (ELOX) News and press releases

Company Profile

News

From Benzinga Pro

Eloxx Pharmaceuticals Plans To Take ELX-02 Into Pivotal Trial For Alport Syndrome

Biotech, News, Health Care, Movers, General

Gold Down 1.5%; Baidu Earnings Top Estimates

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping over 250 points on Tuesday. The Dow traded down 0.81% to 33,079.77 while the NASDAQ rose 0.11% to 12,378.50. The S&P 500, also fell, dropping, 0.38% to 4,120.45.

12 Health Care Stocks Moving In Tuesday's Intraday Session

Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering.

Nasdaq Edges Higher; Home Depot Posts Downbeat Sales

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.58% to 33,155.20 while the NASDAQ rose 0.24% to 12,394.69. The S&P 500, also fell, dropping, 0.24% to 4,126.17.

Dow Tumbles Over 200 Points; US Retail Sales Rise In April

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded lower this morning, with the Dow Jones dropping over 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.71% to 33,111.92 while the NASDAQ fell 0.10% to 12,353.38. The S&P 500, also fell, dropping, 0.38% to 4,120.40.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why VirTra Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

News, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers VivoPower International PLC (NASDAQ: VVPR) shares surged 88.3% to $0.8701 in pre-market trading as the company reported a definitive distribution agreement to distribute EV fleet charging solutions.

Eloxx Pharmaceuticals Q1 EPS $(2.88) Misses $(2.55) Estimate

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(2.88) per share which missed the analyst consensus estimate of $(2.55) by 12.94 percent. This is a 46.27 percent increase over losses of $(5.36) per

Tesla, C3.ai, Rumble, Eloxx, Nu: Why These 5 Stocks Are Drawing Investor Attention Today

Equities, News, Markets

Recap: Eloxx Pharmaceuticals Q1 Earnings

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

10 Short Squeeze Stocks To Watch: Getty Images, Bullfrog AI And A Stock Moving Up 1,687 Positions On Leaderboard

News, Penny Stocks, Small Cap, Trading Ideas

Potential shorts squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits that could lead to a short squeeze.

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session

Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session

Press releases

From Benzinga Pro

Eloxx Pharmaceuticals Reports First Quarter 2023 Financial and Operating Results and Provides Business Update

Earnings, Press Releases

Topline results to include biopsy results for the Phase 2 clinical study evaluating ELX-02 for the potential treatment of Alport syndrome expected in first half of 2023; meaningful protein reduction has been observed in

Eloxx Pharmaceuticals Announces FDA Clearance to Begin Single Ascending Dose Study of ZKN-013

Health Care, Press Releases

ZKN-013 is in development for potential treatment of recessive dystrophic and junctional epidermolysis bullosa (RDEB and JEB) and Familial Adenomatous Polyposis (FAP) ZKN-013 is Eloxx's first drug candidate from its

Thinking about buying stock in Eloxx Pharmaceuticals, Micron Technology, Emergent Biosolutions, Inflarx NV, or TG Therapeutics?

Opinion, Press Releases

NEW YORK, April 10, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ELOX, MU, EBS, IFRX, and TGTX.

Eloxx Pharmaceuticals Reports Fourth Quarter 2022 Financial and Operating Results and Provides Business Update

Earnings, Press Releases

Three patients now dosed in Phase 2 clinical study evaluating ELX-02 for the treatment of Alport syndrome; encouraging initial reduction in proteinuria has been observed in one patient to date Investigational New Drug

Eloxx Pharmaceuticals Announces Submission of Investigational New Drug (IND) Application for ZKN-013

Health Care, Press Releases

ZKN-013 in development for treatment of recessive dystrophic epidermolysis bullosa (RDEB) and junctional epidermolysis bullosa (JEB) Additional IND filing for ZKN-013 for treatment of familial adenomatous polyposis

Eloxx Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference

News, Press Releases

WATERTOWN, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced that it will present at the

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.